Art. 66 Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…

In forcesince 28 Jan 2022cited 3×

The Management Board shall:

(a)

adopt an opinion on the rules of procedures of the Committee for Medicinal Products for Human Use (Article 61 of this Regulation) and the Committee for Veterinary Medicinal Products (Article 139 of Regulation (EU) 2019/6);

(b)

adopt procedures for the performance of scientific services (Article 62);

(c)

appoint the Executive Director (Article 64);

(d)

adopt the annual work programme and forward it to the European Parliament, the Council, the Commission and the Member States (Article 65);

(e)

approve the annual report on the Agency's activities and forward it by 15 June at the latest to the European Parliament, the Council, the Commission, the European Economic and Social Committee, the Court of Auditors and the Member States (Article 65);

(f)

adopt the budget of the Agency (Article 67);

(g)

adopt the internal financial provisions (Article 68);

(h)

adopt provisions implementing the Staff Regulations (Article 75);

(i)

develop contacts with stakeholders and stipulate the conditions applicable (Article 78);

(j)

adopt provisions for providing assistance to pharmaceutical companies (Article 79);

(k)

adopt rules to ensure the availability to the public of information concerning the authorisation or supervision of medicinal products for human use and of veterinary medicinal products (Article 80).

  • Regulation (EU) 2019/5Lawamends

  • Judgment of the Court (Third Chamber) of 22 June 2023. Federal Republic of Germany v European Commission.Decision

    Title IV of Regulation No 726/2004, entitled ‘The European Medicines Agency – Responsibilities and administrative structure’, includes a Chapter 1, itself entitled ‘Tasks of the agency’, comprising Articles 55 to 66 of that same …

    22 Jun 2023 · 62021CJ0006

  • Judgment of the European Union Civil Service Tribunal (Second Chamber),13 November 2014. Emil Hristov v European Commission and European MedDecision

    Article 66 of Regulation No 726/2004 provides that the EMA’s Management Board is to appoint the Executive Director.

    13 Nov 2014 · 62012FJ0002